Northern Trust’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Northern Trust’s Portfolio STAB Stock Details STAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-171,110	Closed	-$13.9K	–	4702
2022 Q4	$13.9K	Hold	171,110	–	–	﹤0.01%	4541
2022 Q3	$22K	Hold	171,110	–	–	﹤0.01%	4533
2022 Q2	$49K	Hold	171,110	–	–	﹤0.01%	4417
2022 Q1	$54K	Buy	171,110 +131,855	+336%	+$141K	﹤0.01%	4520
2021 Q4	$90K	Buy	39,255 +14,312	+57%	+$42.3K	﹤0.01%	4455
2021 Q3	$58K	Buy	24,943 +13,405	+116%	+$50.8K	﹤0.01%	4511
2021 Q2	$63K	Hold	11,538	–	–	﹤0.01%	4454
2021 Q1	$61K	Buy	+11,538	New	+$63.2K	﹤0.01%	4362
2015 Q1	–	Sell	-3,556	Closed	-$20K	–	4363
2014 Q4	$20K	Hold	3,556	–	–	﹤0.01%	4178
2014 Q3	$33K	Sell	3,556 -19	-0.5%	-$174	﹤0.01%	4182
2014 Q2	$35K	Sell	3,575 -33	-0.9%	-$386	﹤0.01%	4141
2014 Q1	$49K	Hold	3,608	–	–	﹤0.01%	4059
2013 Q4	$85K	Hold	3,608	–	–	﹤0.01%	3894
2013 Q3	$113K	Sell	3,608 -57	-2%	-$1.88K	﹤0.01%	3791
2013 Q2	$116K	Buy	+3,665	New	+$126K	﹤0.01%	3782

Other funds holding STAB

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Tucker Asset Management Littleton, Colorado $405M AUM 27.41% 1-Year Est. Return

Northern Trust's STAB Position: Q1 2023 in Review

Northern Trust sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2023, closing a stake of 171,110 shares — an estimated $13.9K sold.

Northern Trust first reported a position in STAB in Q2 2013 and held it in 15 quarters. The position peaked at $116K in Q2 2013. 4 funds tracked by Wall St. Rank hold STAB as of Q1 2023.

Northern Trust reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Northern Trust sold 171,110 Statera Biopharma, Inc. Common Stock shares in Q1 2023, an estimated $13.9K.
Northern Trust first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 15 quarters.
Northern Trust's Statera Biopharma, Inc. Common Stock position peaked at $116K in Q2 2013.
4 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2023.

Based on Northern Trust's 13F filing for Q1 2023, filed 15 May 2023.